PPP3CC

Chr 8

protein phosphatase 3 catalytic subunit gamma

Also known as: CALNA3, CNA3, PP2Bgamma

Calcineurin regulatory subunit gamma encodes a regulatory subunit of calcineurin, a calcium-dependent, calmodulin-stimulated protein phosphatase that dephosphorylates key transcription factors including NFATC1 and ELK1 in calcium-mediated signaling pathways. Mutations cause autosomal recessive severe intellectual disability with progressive spastic paraplegia, affecting both cognitive development and motor function. The gene shows high constraint against loss-of-function variants (LOEUF 0.44), indicating intolerance to protein-disrupting mutations.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
4
Pubs (1 yr)
82
P/LP submissions
0%
P/LP missense
0.44
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryPPP3CC
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.24) despite low pLI — interpret in context.
📋
ClinVar Variants
82 unique Pathogenic / Likely Pathogenic· 69 VUS of 184 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.44LOEUF
pLI 0.264
Z-score 3.86
OE 0.24 (0.130.44)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
1.32Z-score
OE missense 0.78 (0.700.87)
222 obs / 284.4 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.24 (0.130.44)
00.351.4
Missense OE0.78 (0.700.87)
00.61.4
Synonymous OE0.84
01.21.6
LoF obs/exp: 7 / 29.7Missense obs/exp: 222 / 284.4Syn Z: 1.31
DN
0.6647th %ile
GOF
0.6444th %ile
LOF
0.3843th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

184 submitted variants in ClinVar

Classification Summary

Pathogenic78
Likely Pathogenic4
VUS69
Likely Benign6
Benign2
78
Pathogenic
4
Likely Pathogenic
69
VUS
6
Likely Benign
2
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
78
0
78
Likely Pathogenic
0
0
4
0
4
VUS
0
59
10
0
69
Likely Benign
0
2
4
0
6
Benign
0
0
2
0
2
Total061980159

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

PPP3CC · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →